NCT02846233View on ClinicalTrials.gov

Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2018

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

GLP1 receptor agonist

"Albiglutide or Dulaglutide will be added to a basal insulin."

DRUG

basal insulin

The participant will continue with the basal insulin.

DRUG

SGLT2 inhibitor

"Empagliflozin will be added to a basal insulin."

DRUG

Metformin

The participant will continue with metformin.

Trial Locations (1)

93701

UCSF Fresno, Fresno

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT02846233 - Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy? | Biotech Hunter | Biotech Hunter